v3.25.1
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
Preferred Stock [Member]
Series A Preferred Stock [Member]
Preferred Stock [Member]
Series C Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2023 $ 855,808 $ 839,320 $ 10 $ 230,291,834 $ (78,779) $ (224,627,386) $ 7,280,807
Balance, shares at Dec. 31, 2023 85,581 1,688 96,375        
Net loss (2,853,806) (2,853,806)
Other comprehensive income (loss) 87,979 87,979
Stock-based compensation expense 705,770 705,770
Warrant exercises, net $ 1 2,300,688 2,300,689
Warrant exercises, net, shares     13,088        
Balance at Mar. 31, 2024 $ 855,808 $ 839,320 $ 11 233,298,292 9,200 (227,481,192) 7,521,439
Balance, shares at Mar. 31, 2024 85,581 1,688 109,463        
Balance at Dec. 31, 2024 $ 855,808 $ 839,320 $ 14 234,252,981 8,345 (237,819,806) (1,863,338)
Balance, shares at Dec. 31, 2024 85,581 1,688 139,168        
Net loss (6,105,887) (6,105,887)
Other comprehensive income (loss)            
Stock-based compensation expense 20,783 $ 20,783
Warrant exercises, net, shares             8,834,034
Issuance of restricted stock units
Issuance of restricted stock units, shares     1,000        
Issuance of common stock and pre-funded warrants, net $ 55 2,086,537 2,086,592
Issuance of common stock and pre-funded warrants, shares     553,846        
Issuance of common stock in connection with stock split $ 6 (6)
Issuance of common stock and pre-funded warrants, shares     60,860        
Conversion of 2025 Series B warrants into common stock $ 884 9,757,029 9,757,913
Conversion of 2025 Series B warrants into common stock, shares     8,834,034        
Balance at Mar. 31, 2025 $ 855,808 $ 839,320 $ 959 $ 246,117,324 $ 8,345 $ (243,925,693) $ 3,896,063
Balance, shares at Mar. 31, 2025 85,581 1,688 9,588,908